Cargando…

Repositioning of Lansoprazole as a Protective Agent Against Cisplatin-Induced Ototoxicity

Cisplatin (CDDP) is a well-known chemotherapeutic drug approved for various cancers. However, CDDP accumulates in the inner ear cochlea via organic cation transporter 2 (OCT2) and causes ototoxicity, which is a major clinical limitation. Since lansoprazole (LPZ), a proton pump inhibitor, is known to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wakai, Eri, Ikemura, Kenji, Mizuno, Toshiro, Takeuchi, Kazuhiko, Tamaru, Satoshi, Okuda, Masahiro, Nishimura, Yuhei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9336179/ https://www.ncbi.nlm.nih.gov/pubmed/35910376 http://dx.doi.org/10.3389/fphar.2022.896760

Ejemplares similares

An Integrated In Silico and In Vivo Approach to Identify Protective Effects of Palonosetron in Cisplatin-Induced Nephrotoxicity
por: Wakai, Eri, et al.
Publicado: (2020)

Drug Repositioning of Proton Pump Inhibitors for Enhanced Efficacy and Safety of Cancer Chemotherapy
por: Ikemura, Kenji, et al.
Publicado: (2017)

Current Strategies to Combat Cisplatin-Induced Ototoxicity
por: Yu, Dehong, et al.
Publicado: (2020)

Editorial: Drug Repositioning: Current Advances and Future Perspectives
por: Nishimura, Yuhei, et al.
Publicado: (2018)

Overcoming Obstacles to Drug Repositioning in Japan
por: Nishimura, Yuhei, et al.
Publicado: (2017)

Effect of number of medications and complexity of regimens on medication adherence and blood pressure management in hospitalized patients with hypertension
por: Wakai, Eri, et al.
Publicado: (2021)

Risk factors for the development of hypermagnesemia in patients prescribed magnesium oxide: a retrospective cohort study
por: Wakai, Eri, et al.
Publicado: (2019)

Cisplatin ototoxicity histopathology
por: Hodge, Sarah E., et al.
Publicado: (2021)

Risk factors for cisplatin-induced acute kidney injury: A pilot study on the usefulness of genetic variants for predicting nephrotoxicity in clinical practice
por: Oda, Hiroyasu, et al.
Publicado: (2020)

The Effect of Dexpanthenol on Ototoxicity Induced by Cisplatin
por: Toplu, Yuksel, et al.
Publicado: (2016)

Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection
por: Sheth, Sandeep, et al.
Publicado: (2017)

The Effects of Riluzole on Cisplatin-induced Ototoxicity
por: Üstün Bezgin, Selin, et al.
Publicado: (2019)

Mechanisms of Aminoglycoside- and Cisplatin-Induced Ototoxicity
por: Steyger, Peter S.
Publicado: (2021)

Editorial: Pharmacovigilance and drug repositioning research using pharmacoepidemiology
por: Noguchi, Yoshihiro, et al.
Publicado: (2023)

A Case of Hyperammonemia Associated with High Dihydropyrimidine Dehydrogenase Activity
por: Nagaharu, Keiki, et al.
Publicado: (2016)

Calpain mediated cisplatin-induced ototoxicity in mice
por: Chang, Liang, et al.
Publicado: (2013)

Otoprotective Effects of Zingerone on Cisplatin-Induced Ototoxicity
por: Lee, Chang Ho, et al.
Publicado: (2020)

Mitophagy Impairment Aggravates Cisplatin-Induced Ototoxicity
por: Cho, Sung Il, et al.
Publicado: (2021)

Oxidative Stress and Inflammation Caused by Cisplatin Ototoxicity
por: Ramkumar, Vickram, et al.
Publicado: (2021)

The role of apoptosis in cisplatin-induced ototoxicity in rats
por: De Freitas, Marcos Rabelo, et al.
Publicado: (2015)

The effectiveness of eugenol against cisplatin-induced ototoxicity()
por: Sakat, Muhammed Sedat, et al.
Publicado: (2018)

Subclinical diagnosis of cisplatin-induced ototoxicity with biomarkers
por: Generotti, Charles, et al.
Publicado: (2022)

Analysis of Gene-Environment Interactions Related to Developmental Disorders
por: Nishimura, Yuhei, et al.
Publicado: (2022)

Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity
por: Borse, Vikrant, et al.
Publicado: (2017)

Dynamic Editome of Zebrafish under Aminoglycosides Treatment and Its Potential Involvement in Ototoxicity
por: Yan, Sijia, et al.
Publicado: (2017)

Protective Effect of Minocycline Against Cisplatin-induced Ototoxicity
por: Lee, Chi-Kyou, et al.
Publicado: (2011)

Dexmedetomidine Preconditioning Attenuates Cisplatin-Induced Ototoxicity in Zebrafish
por: Min, Too Jae, et al.
Publicado: (2014)

Protective Effect of Tempol against Cisplatin-Induced Ototoxicity
por: Youn, Cha Kyung, et al.
Publicado: (2016)

Cisplatin-Associated Ototoxicity: A Review for the Health Professional
por: Paken, Jessica, et al.
Publicado: (2016)

The genetic vulnerability to cisplatin ototoxicity: a systematic review
por: Tserga, Evangelia, et al.
Publicado: (2019)

Cisplatin-Induced Ototoxicity: Effects, Mechanisms and Protection Strategies
por: Callejo, Angela, et al.
Publicado: (2015)

Supporting Cells and Their Potential Roles in Cisplatin-Induced Ototoxicity
por: Waissbluth, Sofia, et al.
Publicado: (2022)

The effect of genistein on cisplatin induced ototoxicity and oxidative stress
por: Tan, Mehmet, et al.
Publicado: (2021)

The use of Maytenus ilicifolia to prevent cisplatin-induced ototoxicity
por: Kasse, Cristiane Akemi, et al.
Publicado: (2015)

Curcumin Prevents Ototoxicity Induced by Cisplatin as Evaluated with OAE
por: Arwanda, Muhammad Dana, et al.
Publicado: (2023)

Molecular Characteristics of Cisplatin-Induced Ototoxicity and Therapeutic Interventions
por: Tan, Winston J. T., et al.
Publicado: (2023)

Drug repositioning: A bibliometric analysis
por: Sun, Guojun, et al.
Publicado: (2022)

Lansoprazole promotes cisplatin‐induced acute kidney injury via enhancing tubular necroptosis
por: Ye, Lin, et al.
Publicado: (2021)

Concomitant palonosetron ameliorates cisplatin-induced nephrotoxicity, nausea, and vomiting: a retrospective cohort study and pharmacovigilance analysis
por: Takemura, Miho, et al.
Publicado: (2022)

Amygdalin as a chemoprotective agent in co-treatment with cisplatin
por: Christodoulou, Panayiota, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tmtkp2m5edvknh642n7jr9qb0n